![Lucinda Quan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Lucinda Y.
Quan was the founder of Aligos Therapeutics, Inc. since 2018, serving as Chief Business Officer, EVP & General Counsel.
Former job at Merck & Co., Inc. as Executive Director-Business Development from 2016 to 2018.
Former job at InterMune, Inc. as VP-Legal Affairs & Associate General Counsel from 2004 to 2013.
Former job at Alios BioPharma, Inc. as Vice President & Head-Legal Affairs from 2013 to 2016.
Education includes undergraduate and graduate degrees from the University of California, Los Angeles.
Former positions of Lucinda Quan
| Companies | Position | End |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Founder | 2023-11-30 |
| MERCK & CO., INC. | Corporate Officer/Principal | 2018-03-31 |
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | General Counsel | 2015-12-31 |
| INTERMUNE INC | General Counsel | 2013-10-31 |
Training of Lucinda Quan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
- Stock Market
- Insiders
- Lucinda Quan
